|
⚲
|
| Keyboard |
| Champions Oncology Inc | |
|---|---|
| Ticker | CSBR |
| CIK # | 0000771856 |
| CUSIP | 15870P307 |
| Sector | Life Sciences - Biological Products, (No Disgnostic Substances) |
| Address | 855 N Wolfe Street Suite 619, Baltimore, MD 21205 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Champions Oncology Inc | 2015-03-25 | 14.0 M | Exemption: 506(b) · Minimum: $1 · Duration: One year or less · Commission: $640,500 · Revenue: $5,000,001 - $25,000,000 |
| Champions Biotechnology Inc | 2010-11-01 | Exemption: 506 · Remaining: Indefinite · Duration: One year or less · Revenue: $1,000,001 - $5,000,000 |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0000771856] | 10-K | |
| [0000771856] | 10-Q | |
| [0000771856] | 3 | |
| [0000771856] | 4 | |
| [0000771856] | 8-K | |
| [0000771856] | D | |
| [0000771856] | SC 13D | |
| [0000771856] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Tocqueville Asset Management LP | Champions Oncology Inc | [2024-02-12] | 5.0 |
| West Elk Partners LP | Champions Oncology Inc | [2021-07-23] | 5.06 |
| Pessin Norman H | Champions Oncology Inc | [2017-01-13] | 1.0 |
| Fields Ephraim G | Champions Oncology Inc | [2016-12-13] | 5.8 |
| New Enterprise Associates 14 LP | Champions Oncology Inc | [2015-03-24] | 25.4 |
| [2013-02-04] | None | ||
| [2013-02-01] | None | ||
| Par Investment Partners LP | Champions Oncology Inc | [2013-01-30] | 16.2 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mendelson Daniel Newman
Option to purchase Common Stock · derivative
|
2025-11-05 | Grant | 13,790 | $6.80 | 93,772 |
|
Ackerman Joel
Option to purchase Common Stock · derivative
|
2025-11-05 | Grant | 21,216 | $6.80 | 144,269 |
|
Sidransky David
Option to purchase Common Stock · derivative
|
2025-11-05 | Grant | 21,216 | $6.80 | 144,269 |
|
Tobin Scott R
Option to purchase Common Stock · derivative
|
2025-11-05 | Grant | 25,460 | $6.80 | 173,128 |
|
Breitfeld Philip P
Option to purchase Common Stock · derivative
|
2025-11-05 | Grant | 13,790 | $6.80 | 93,772 |
|
Ackerman Joel
Common Stock
|
2025-10-30 | Option exercise | 94,405 | $2.10 | 198,250 |
|
Ackerman Joel
Option to purchase Common Stock · derivative
|
2025-10-30 | Option exercise | 94,405 | $2.10 | 198,250 |
|
Brainin Robert Lawrence
Option to purchase Common Stock · derivative
|
2025-07-16 | Grant | 150,000 | $7.80 | 1,170,000 |
|
Brainin Robert Lawrence
Option to purchase Common Stock · derivative
|
2025-07-16 | Grant | 62,500 | $7.80 | 487,500 |
|
Brainin Robert Lawrence
Option to purchase Common Stock · derivative
|
2025-07-16 | Grant | 100,000 | $7.80 | 780,000 |
|
Brainin Robert Lawrence
Option to purchase Common Stock · derivative
|
2025-07-16 | Grant | 225,000 | $7.80 | 1,755,000 |
|
Brainin Robert Lawrence
Option to purchase Common Stock · derivative
|
2025-07-16 | Grant | 62,500 | $7.80 | 487,500 |
|
Brainin Robert Lawrence
Option to purchase Common Stock · derivative
|
2025-07-16 | Grant | 100,000 | $7.80 | 780,000 |
|
Breitfeld Philip P
Common Stock
|
2025-03-25 | Other | 4,150 | $0.00 | |
|
Brainin Robert Lawrence
Option to purchase Common Stock · derivative
|
2024-11-12 | Grant | 23,030 | $4.64 | 106,859 |
|
Mendelson Daniel Newman
Option to purchase Common Stock · derivative
|
2024-11-12 | Grant | 21,590 | $4.64 | 100,178 |
|
Ackerman Joel
Option to purchase Common Stock · derivative
|
2024-11-12 | Grant | 43,190 | $4.64 | 200,402 |
|
Breitfeld Philip P
Option to purchase Common Stock · derivative
|
2024-11-12 | Grant | 18,715 | $4.64 | 86,838 |
|
Tobin Scott R
Option to purchase Common Stock · derivative
|
2024-11-12 | Grant | 34,550 | $4.64 | 160,312 |
|
Sidransky David
Option to purchase Common Stock · derivative
|
2024-11-12 | Grant | 21,880 | $4.64 | 101,523 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 26 | 5,755,536 |
| 2025-12-31 | 28 | 5,786,821 |
| 2025-09-30 | 27 | 5,663,116 |
| 2025-06-30 | 33 | 5,816,007 |
| 2025-03-31 | 35 | 5,962,869 |
| 2024-12-31 | 26 | 5,741,472 |
| 2024-09-30 | 24 | 5,798,736 |
| 2024-06-30 | 24 | 5,783,569 |
| 2024-03-31 | 26 | 5,726,822 |
| 2023-12-31 | 25 | 5,660,282 |
| 2023-09-30 | 31 | 5,757,095 |
| 2023-06-30 | 31 | 6,040,240 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Capital Advisors Ltd LLC | [2026-06-30] | SOLE | 0 | 48 | Prev | Page 1 | Next |